These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13433530)

  • 1. [Abnormal oxidative activity in blood serum in schizophrenia].
    MARTENS S
    Sven Lakartidn; 1957 Mar; 54(12):868-72. PubMed ID: 13433530
    [No Abstract]   [Full Text] [Related]  

  • 2. The oxidative activity of blood serum in schizophrenic and manic-depressive psychoses.
    WURTMAN RJ; FRANK MM; ALTSCHULE MD
    AMA Arch Intern Med; 1958 Nov; 102(5):790-4. PubMed ID: 13582265
    [No Abstract]   [Full Text] [Related]  

  • 3. Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.
    Sarandol A; Kirli S; Akkaya C; Altin A; Demirci M; Sarandol E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1164-9. PubMed ID: 17459548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Oxidative Stress Marker Levels in Unmedicated and Medicated Patients with Schizophrenia.
    Bai ZL; Li XS; Chen GY; Du Y; Wei ZX; Chen X; Zheng GE; Deng W; Cheng Y
    J Mol Neurosci; 2018 Nov; 66(3):428-436. PubMed ID: 30298298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Some data on the dynamics of proteolytic and trypsin-inhibiting activity of blood serum from patients with schizophrenia].
    OLEINIK AV
    Fiziol Zh; 1962; 8():405-9. PubMed ID: 14481723
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot study of biomarkers of oxidative stress in serum and schizophrenia.
    Ma J; Yan L; Guo T; Yang S; Ni D; Liu Y; Wang J
    Psychiatry Res; 2020 Feb; 284():112757. PubMed ID: 31955055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-year study on the occurrence of an abnormal blood factor (taraxein) in schizophrenia].
    MARTENS S
    Sven Lakartidn; 1961 Oct; 58():3072-84. PubMed ID: 14470300
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum enzyme activity in chronic schizophrenia.
    ANTEBI RN; KING J
    J Ment Sci; 1962 Jan; 108():75-9. PubMed ID: 13861752
    [No Abstract]   [Full Text] [Related]  

  • 9. The novel oxidative stress marker thioredoxin is increased in first-episode schizophrenic patients.
    Zhang XY; Chen DC; Xiu MH; Wang F; Qi LY; Sun HQ; Chen S; He SC; Wu GY; Haile CN; Kosten TA; Lu L; Kosten TR
    Schizophr Res; 2009 Sep; 113(2-3):151-7. PubMed ID: 19540723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study.
    Chittiprol S; Venkatasubramanian G; Neelakantachar N; Babu SV; Reddy NA; Shetty KT; Gangadhar BN
    J Psychiatr Res; 2010 Apr; 44(5):310-3. PubMed ID: 19850302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the toxicity of schizophrenic blood serum.
    EDISEN CB
    Dis Nerv Syst; 1956 Mar; 17(3):77-80. PubMed ID: 13305456
    [No Abstract]   [Full Text] [Related]  

  • 12. [The problem of serum proteins in schizophrenia].
    CZETTELE K
    Ideggyogy Sz; 1955 Dec; 8(6):174-8. PubMed ID: 13345392
    [No Abstract]   [Full Text] [Related]  

  • 13. [Abnormal thrombocytes in schizophrenia: electron microscopy observation].
    Xalabarder C
    Agressologie; 1973 Aug; 14(4):275-9. PubMed ID: 4794177
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxicity of schizophrenics' blood serum in tissue culture.
    FEDOROFF S
    J Lab Clin Med; 1956 Jul; 48(1):55-62. PubMed ID: 13332340
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated serum protein oxidative stress in siblings of patients with schizophrenia.
    Massuda R; Pedrini M; Reckziegel R; Costanzi M; Ferrari P; Gubert C; Gama CS
    Schizophr Res; 2013 Jul; 147(2-3):398-9. PubMed ID: 23664585
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patients.
    van Rees GF; Lago SG; Cox DA; Tomasik J; Rustogi N; Weigelt K; Ozcan S; Cooper J; Drexhage H; Leweke FM; Bahn S
    Brain Behav Immun; 2018 Jan; 67():364-373. PubMed ID: 28988033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remarks on Fischer's article, Stress and the toxicity of schizophrenic serum.
    GEORGI F; RIEDER HP; WEBER R; FISCHER R
    Science; 1954 Sep; 120(3117):504-6. PubMed ID: 13195689
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.
    Tsai MC; Liou CW; Lin TK; Lin IM; Huang TL
    Psychiatry Res; 2013 Oct; 209(3):284-90. PubMed ID: 23497820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The action of blood serum from schizophrenic patients on the electric activity of the brain in experimental animals. 3. On the multiple components of the active factor in the blood serum of patients with periodic schizophrenia].
    Nemtsov AV; Faivishevskiĭ VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1965; 65(8):1197-200. PubMed ID: 5868213
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicity of blood serum from schizophrenic and non-schizophrenic subjects.
    FEDOROFF S; HOFFER A
    J Nerv Ment Dis; 1956 Oct; 124(4):396-8. PubMed ID: 13449632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.